Saturday, June 13, 2026

Patent directory · USPTO A61K / A61P

Patents matching “ONC”

274 pharma patents match "ONC" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 274
Index total 30,257
Page 11 / 12

Quick answer

This filtered view shows 274 pharmaceutical patents matching "ONC" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

274 results for “ONC” · 30,257 patents in full index Clear search

  1. US 7229986

    Melanin-concentrating hormone antagonist

    Takeda Pharmaceutical Company Limited · Granted Jun 12, 2007 · Expires Jun 7, 2027

    granted
  2. US 7223585

    Viral purification methods

    ONCOLYTICS BIOTECH INC. · Granted May 29, 2007 · Expires May 24, 2027

    granted
  3. US 7198783

    Sensitization of neoplastic cells to radiation therapy with reovirus

    ONCOLYTICS BIOTECH INC. · Granted Apr 3, 2007 · Expires Mar 29, 2027

    granted
  4. US 7195876

    Oncokinase fusion polypeptides associated with hyperproliferative and related disorders, nucleic acids encoding the same and methods for detecting and identifying the same

    Theravance, Inc. · Granted Mar 27, 2007 · Expires Mar 22, 2027

    granted
  5. US 7186542

    Method of extracting virus from cell culture

    ONCOLYTICS BIOTECH INC. · Granted Mar 6, 2007 · Expires Mar 1, 2027

    granted
  6. US 7163678

    Reovirus for the treatment of ral-mediated cellular proliferative disorders

    ONCOLYTICS BIOTECH INC. · Granted Jan 16, 2007 · Expires Jan 11, 2027

    granted
  7. US 7052832

    Methods for the treatment of cellular proliferative disorders

    ONCOLYTICS BIOTECH INC. · Granted May 30, 2006 · Expires May 25, 2026

    granted
  8. US 7049127

    Method of producing infectious reovirus

    ONCOLYTICS BIOTECH INC. · Granted May 23, 2006 · Expires May 18, 2026

    expired
  9. US 7014847

    Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders

    ONCOLYTICS BIOTECH INC. · Granted Mar 21, 2006 · Expires Mar 16, 2026

    expired
  10. US 6994858

    Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions

    ONCOLYTICS BIOTECH INC. · Granted Feb 7, 2006 · Expires Feb 2, 2026

    expired
  11. US 6930185

    Melanin-concentrating hormone antagonist

    Takeda Chemical Industries Ltd. · Granted Aug 16, 2005 · Expires Aug 11, 2025

    expired
  12. US 6863888

    Oncoprotein protein kinase

    The Regents of the University of California · Granted Mar 8, 2005 · Expires Mar 3, 2025

    expired
  13. US 6846644

    Oncoprotein protein kinase

    The Regents of the University of California · Granted Jan 25, 2005 · Expires Jan 20, 2025

    expired
  14. US 6811775

    Reovirus for the treatment of cellular proliferative disorders

    ONCOLYTICS BIOTECH INC. · Granted Nov 2, 2004 · Expires Oct 28, 2024

    expired
  15. US 6808916

    Method of extracting virus from cell culture

    ONCOLYTICS BIOTECH INC. · Granted Oct 26, 2004 · Expires Oct 21, 2024

    expired
  16. US 6706509

    Oncoprotein protein kinase

    The Regents of the University of California · Granted Mar 16, 2004 · Expires Mar 11, 2024

    expired
  17. US 6703232

    Method of producing infectious reovirus

    ONCOLYTICS BIOTECH INC. · Granted Mar 9, 2004 · Expires Mar 4, 2024

    expired
  18. US 6673559

    Met proto-oncogene and a method for predicting breast cancer progression

    The United States of America as Represented by the Government of the Department of Health and Human Services · Granted Jan 6, 2004 · Expires Jan 1, 2024

    expired
  19. US 6649157

    Viruses for the treatment of cellular proliferative disorders

    ONCOLYTICS BIOTECH INC. · Granted Nov 18, 2003 · Expires Nov 13, 2023

    expired
  20. US 6610505

    Oncoprotein protein kinase

    The Regents of the University of California · Granted Aug 26, 2003 · Expires Aug 21, 2023

    expired
  21. US 6596268

    Viruses for the treatment of cellular proliferative disorders

    ONCOLYTICS BIOTECH INC. · Granted Jul 22, 2003 · Expires Jul 17, 2023

    expired
  22. US 6576234

    Reovirus for the treatment of neoplasia

    ONCOLYTICS BIOTECH INC. · Granted Jun 10, 2003 · Expires Jun 5, 2023

    expired
  23. US 6565831

    Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders

    ONCOLYTICS BIOTECH INC. · Granted May 20, 2003 · Expires May 15, 2023

    expired
  24. US 6528305

    Method of producing infectious reovirus

    ONCOLYTICS BIOTECH INC. · Granted Mar 4, 2003 · Expires Feb 27, 2023

    expired